Article Type : Research Article
Authors : Praveen Kumar Annagowni, Mudalagi SV, Desai AR, Patil RR, Rukhaiya CR, Shashank SM, Swati SM, Hundekar SM and Vijapur LS
Keywords : Quercetin; Gallic acid; Emulgel; Anti-acne activity; Antimicrobial activity
Aim:
To formulate and evaluate antiacne emulgel containing quercetin and gallic
acid.
Objectives:
Quercetin and Gallic acid are effective against acne causing micro-organisms.
The main aim of the present work is to develop anti-acne emulgel of Quercetin
and Gallic acid for the treatment and management of acne.
Methodology:
Quercetin and Gallic acid were calibrated using UV-Visible Spectrophotometer.
The anti-acne emulgel of Quercetin and Gallic acid were prepared by mixing gel
base and emulsion to form emulgel was formed using carbopol-940. The prepared
anti-acne emulgel formulations were evaluated for in- vitro drug release, drug
content, pH, spreadability, extrudability, viscosity & evaluated for
microbial inhibition by disc diffusion.
Results:
Anti-acne emulgel comprising of Quercetin and Gallic acid were successfully
developed. The emulgel formulations exhibited improved in-vitro drug release,
with cumulative drug content ranging from 94.39 – 97.53%(Quercetin), 97.1-
99.5% (Gallic acid). pH ranging from 5.32 -5.45, Extrudability 90.2- 96.6%.
Viscosity 583.1-594.5. Vesicle size 1713 -1957.5?m, Zone of inhibition was 12 –
13mm for S. epidermis & 8- 12mm P.acne.
Conclusion:
The formulated emulgel containing quercetin and gallic acid demonstrated
outstanding effectiveness in inhibiting the growth of acne-causing
microorganisms.
Acne
is a long-term inflammatory condition that affects the pilosebaceous unit,
which includes hair follicles and sebaceous glands [1]. It is mainly caused by
the effect of androgens, which increase sebum production, and is also linked to
the presence of the bacterium Propionibacterium acnes. Other microorganisms
that can contribute to acne include Staphylococcus epidermis, Escherichia coli,
Staphylococcus aureus, and Pseudomonas aeruginosa [2]. An emulgel is a type of
formulation that is created by gelling an emulsion with the help of a gelling
agent. It can be of two types, either water-in-oil (w/o) or oil-in-water (o/w).
Emulgels are effective in delivering medicines in both water-soluble and
oil-based forms. They offer numerous benefits such as easy application, lack of
greasiness, thixotropy (ability to change consistency when subjected to
stress), long shelf life, being odourless, and having an appealing appearance
[3]. Quercetin is considered a promising treatment for acne due to its strong
anti-inflammatory and antibacterial properties. It helps to reduce inflammation
by preventing the production of tumor necrosis factor alpha (TNF-?), which
plays a key role in chronic inflammatory conditions, and it also inhibits the
production of other inflammatory substances [4]. Gallic acid is a crystalline
substance that is either slightly colourless or has a slight yellow tinge. It
has various health benefits, including antibacterial, anti-tumour,
anti-diabetic, anti-obesity, anti-microbial, and anti-anginal properties [5].
Materials
Gallic
acid, Quercetin, and Carbopol 940 were obtained from Loba Chemical Pvt Ltd,
Mumbai. Liquid paraffin and Tween 20 were purchased from SDFCL Fine Chemical
Ltd, Mumbai. Propylene glycol was sourced from Thermo Fisher Scientific India
Pvt Ltd, Mumbai. Methyl paraben was acquired from NR CHEM Mumbai, and Propyl
paraben was obtained from Genuine Chemical Co., Bombay.
Methodology
Preparation of gel base
Carbopol
940 was soaked in distilled water for 24 hours until it swelled and formed a
gel base.
Preparation of Anti- Acne
emulgel
An oil phase was made by mixing Quercetin, Liquid Paraffin, Propylene glycol, Propyl paraben, and a water phase was prepared using Gallic acid, Tween 20, Methyl paraben, and distilled water. Both phases were blended and homogenized to form an emulsion. The emulsion was then mixed with the Carbopol 940 gel base to produce the final emulgel [6] (Table 1).
Figure 1: Standard Calibration Curve.
Figure
2: Standard Calibration Curve of Gallic Acid.
Figure 3: Evaluation of Spreading Coefficient.
Figure 4: Evaluation of viscosity.
Figure
5: Evaluation of Extrudability.
Figure 6: In vitro Drug Release of Quercetin.
Figure 7: In vitro Drug Release of Gallic acid.
[a]
[b]
[c]
Figure 8: [a, b & c] Anti-microbial activity of S. epidermidis.
F1=10mm F2=12mm F3=8mm
Figure
9: [a, b & c] Anti-microbial activity of P. acne.
Table 1: Composition of Anti- Acne emulgel.
|
SLNO. |
INGREDIENTS (100 gm) |
F1 |
F2 |
F3 |
|
1. |
Gallic Acid |
0.2 |
0.4 |
0.6 |
|
2. |
Quercetin |
0.05 |
0.075 |
0.1 |
|
3. |
Carbopol 940 |
2 |
2 |
2 |
|
4. |
Liquid Paraffin |
7.48 |
7.48 |
7.48 |
|
5. |
Tween20 |
1.4 |
1.4 |
1.4 |
|
6. |
Propylene glycol |
5 |
5 |
5 |
|
7. |
Methyl paraben |
0.03 |
0.03 |
0.03 |
|
8. |
Propyl paraben |
0.02 |
0.02 |
0.02 |
|
9. |
Distilled water |
q.s |
q.s |
q.s |
|
10. |
Lavender oil |
q.s |
q.s |
q.s |
Table 2: Evaluation results of Physical Appearance.
|
Colour |
Creamish White |
|
Texture |
Smooth,
Uniform |
|
Odour |
Pleasant |
Physical Characterization
The
color, odor, and texture of the prepared emulgels were visually examined to
assess their physical properties [7].
Calibration
Calibration
curves for quercetin and gallic acid were developed using the UV-Visible
spectrophotometric method. Standard solutions were prepared by dissolving known
amounts of quercetin and gallic acid in methanol to create stock solutions of
known concentration (e.g., 100 µg/mL). Appropriate dilutions were made to
prepare solutions in the range of 2–20 µg/mL for quercetin and 5–30 µg/mL for
gallic acid. Absorbance was measured at 372 nm and 256 nm, respectively [8,9].
Vesicle size
The
calibration of the eyepiece micrometer was done using a stage micrometer. The
emulgel was spread on a slide, and 500 vesicles were counted. Using the
calibration factor, the average size of the vesicles was calculated [10].
pH
The
pH of the prepared emulgel was measured using a digital pH meter. The glass
electrode was dipped into the emulgel for one minute, and the pH was recorded.
Each formulation was tested in triplicate, and the mean value was calculated
[11].
Spreading coefficient
The
spreading coefficient was determined using a house developed apparatus. It
consisted of a wooden block attached to a pulley. The emulgel was placed on a
ground glass slide, which was fixed on the block. A second glass slide was
placed on top, and a weight of 20gram was placed on the two slides for 5
minutes to expel air and create a uniform film of the emulgel. A known weight
was placed on the pulley, and the time required for the top slide to travel 5
cm was measured. A shorter time indicated better spreading [12].
S=????× ????/ ????
Where
S = Spreadability
M
= Weight in the Pan (tied to the upper slide) in gm
L
= Length moved by the glass slide in cm
Viscosity
The
viscosity of the prepared gel was measured using a Brookfield Viscometer. The
gels were rotated at 50 rpm using spindle number 64, and the dial reading was
recorded [13].
Extrudability
About
5 grams of the emulgel was filled into a clean, lacquered aluminium collapsible
tube. A clamp was applied to prevent the product from flowing back. The cap was
removed, and the emulgel was extruded through the tip. The extruded emulgel was
collected and weighed. The percentage of extrudability was calculated by
dividing the amount of emulgel extruded by the total amount in the tube and
multiplying by 100 [14].
Percentage
extrudability = Amount of gel extruded from tube/ Total amount of gel in tube
X
100
(>90%
Extrudability: Excellent)
(>80%
extrudability: good)
Drug Content
The
drug content in the emulgel was determined using a spectrophotometer. A known
quantity of emulgel was dissolved in a suitable solvent using sonication. The
absorbance was measured after appropriate dilution in a UV/VIS
spectrophotometer. Gallic acid was measured in water at 256 nm, and quercetin
was measured in methanol at 372 nm [15].
In Vitro drug release
studies
The
in vitro drug release behavior of the anti-acne emulgel formulations was
evaluated using a locally built setup. It included a donor compartment and a
receptor compartment with an effective diffusion area of 3 cm² and a length of
10 cm. A certain volume of emulgel was placed in the donor compartment, while
50 mL of PBS (pH 6.8) was placed in the receptor compartment. The setup was
maintained at 37 ± 0.5°C with continuous stirring at 50 rpm. 1ml sample
withdrawn from the sampling port at 1, 2. 3, 4. 5, and 6 hours. The withdrawn
sample is immediately replaced with a fresh buffer to attain a fixed volume.
The samples were subjected to spectrophotometric examination at 372 & 256
nm for Quercetin and Gallic acid respectively, using PBS (pH 6.8) as a blank.
After carrying out the in vitro release experiments in triplicate, the results
were analyzed to determine the drug release kinetics from the different
formulations [16].
Anti-Microbial Test
Procedures:
Disc Diffusion Test
01) Media used: - Brain Heart Infusion agar
02) Temperature: - Bring agar plates to room
temperature before use.
Appearance
All
the prepared gel formulations were visually analyzed they were found to be
clear and there was no aggregation
found and free from presence of particles (Figures 1-7) (Table 2).
Visual appearance and
Homogeneity
The
prepared anti-acne emulgel formulations were transferred into clean,
transparent containers and subjected to visual inspection to evaluate their
physical appearance, color, and homogeneity. This evaluation is an essential
preliminary step in assessing the overall quality and acceptability of topical
formulations. All formulations exhibited a uniform and smooth appearance with
consistent color throughout, indicating proper mixing and uniform dispersion of
both the aqueous and oily phases. No visible signs of phase separation,
creaming, cracking, or sedimentation were observed during the inspection
period, suggesting that the emulsification process was effective and the
formulations were physically stable.
pH Determination
The
pH of all formulated anti-acne emulgels was determined using a calibrated
digital pH meter to ensure accuracy and reliability of the measurements. Prior
to analysis, the pH meter was standardized using appropriate buffer solutions,
and the measurements were performed at room temperature. The pH values of the
developed formulations were found to range between 5.32 ± 0.02 and 5.45 ± 0.03,
indicating minimal variation among the different emulgel batches. This pH range
closely corresponds to the normal physiological pH of human skin, which is
typically mildly acidic in nature (Table 6). The observed pH values suggest
that the emulgels are unlikely to cause discomfort or adverse skin reactions
upon application.
Extrudability
Extrudability
is a critical evaluation parameter for topical semisolid formulations, as it
indicates the ease with which the product can be expelled from a collapsible
tube or container under the application of gentle pressure. This property is
closely related to the viscosity, consistency, and gel strength of the
formulation, all of which influence patient convenience and compliance. In the
present study, the extrudability of all prepared anti-acne emulgel formulations
was assessed, and the results demonstrated that each formulation possessed
satisfactory extrudability, reflecting an appropriate balance between firmness
and flowability.
Among
the evaluated formulations, F2 exhibited superior extrudability when compared
to F1 and F3. This observation suggests that formulation F2 achieved an optimal
viscosity and gel structure, allowing it to be smoothly and uniformly extruded
without requiring excessive force. In contrast, slightly lower extrudability
observed in the other formulations may be attributed to higher viscosity or
increased gel strength. Adequate extrudability is essential to ensure ease of
application, accurate dosing, and uniform spreading of the formulation over the
skin surface. Therefore, the favourable extrudability characteristics of the
developed emulgels, particularly formulation F2, indicate their suitability for
topical anti-acne therapy and enhance their potential for effective and
user-friendly application (Figure 5 & Table 9).
Viscosity
Viscosity
is a key rheological parameter that significantly influences the performance,
stability, and patient acceptability of topical semisolid formulations. In the
present study, viscosity measurements were carried out for all formulated
anti-acne emulgels to evaluate their flow behaviour and suitability for topical
administration. The results indicated that all formulations possessed adequate
viscosity, demonstrating appropriate consistency for application onto the skin.
The observed viscosity values suggest that the emulgels can maintain their
structure and remaining at the site of application for a prolonged period,
which is essential for sustained contact with the skin and improved therapeutic
efficacy of the active ingredients.
Comparative
evaluation revealed that formulation F3 exhibited relatively higher viscosity
than the other formulations, which may be attributed to a higher concentration
of gelling agent or increased intermolecular interactions within the gel
matrix. While higher viscosity can enhance residence time at the application
site, excessively viscous formulations may hinder spreadability. In contrast,
formulations F1 and F2 displayed moderate viscosity, offering a favorable
balance between consistency and ease of spreading. This moderate viscosity is
advantageous as it allows uniform application with minimal effort, thereby
improving patient comfort and compliance (Figure 4) (Table 8). Overall, the
viscosity characteristics of the developed emulgels indicate their suitability
for topical anti-acne therapy, with each formulation exhibiting desirable
rheological properties tailored for effective skin application.
Spreadability
Spreadability
studies indicated that the anti-acne emulgels spread easily upon application of
minimal shear. Formulations with relatively lower viscosity demonstrated higher
spreadability. The observed spreadability values confirm that the emulgels can
be uniformly applied over the skin surface with minimal effort. This property
enhances patient comfort and ensures better drug distribution at the
application site.
The
spreadability of the anti-acne emulgel formulations was evaluated to assess
their ease of application and ability to uniformly distribute over the skin
surface. Among the tested formulations, F2 exhibited the highest spreading
coefficient (72.46 ± 0.896 gm·cm/sec) and the shortest spreading time (2.07
sec), indicating superior spreadability compared to the other formulations.
This suggests that formulation F2 possessed optimal viscosity and consistency,
allowing it to spread easily with minimal applied force. Formulation F1 showed
moderate spreadability with a spreading coefficient of 66.66 ± 0.782 gm·cm/sec
and a spreading time of 2.25 sec, reflecting acceptable spreading
characteristics. In contrast, formulation F3 demonstrated the lowest spreading
coefficient (56.81 ± 0.989 gm·cm/sec) and the longest spreading time (2.64 sec)
(Figure 3) (Table 7), which may be attributed to its comparatively higher
viscosity.
Vesicle size
The
vesicle size of the formulated anti-acne emulgels was determined using an
optical microscopic method. Formulations F2 and F3 exhibited nearly similar
vesicle sizes when compared to F1. The results indicate that a reduction in
vesicle size enhances the surface area available for drug release, thereby
potentially improving drug permeation and therapeutic efficacy (Table 5). The optimized vesicle size also
contributes to formulation stability and controlled drug release.
Antimicrobial activity
The
formulated anti-acne emulgel formulations were subjected to antimicrobial
activity on S. epidermidis and P. acne organisms. On antimicrobial
studies by disc diffusion method, it was found that F2 was having greater
diameter of zone of inhibition as compared to F1 and F3 formulation (Figure 8
& 9).
The
present investigation successfully developed and evaluated a topical emulgel
formulation. The prepared emulgels were systematically examined for key
physicochemical parameters such as pH, viscosity, spreadability, extrudability,
vesicle size, drug content, in-vitro drug release, and antimicrobial activity.
All measured parameters were found to fall within acceptable limits, confirming
the suitability of the formulation for topical drug delivery. Among the
different batches, the optimized formulation exhibited appropriate viscosity
and excellent spreadability, allowing smooth application and uniform
distribution over the skin with minimal shear stress. The extrudability
findings further indicated that the formulation could be conveniently dispensed
from the container, thereby improving patient compliance and ease of use.
In-vitro
drug release studies demonstrated that the emulgels provided satisfactory and
controlled drug release profiles. Notably, formulations F2 and F3 showed
comparatively higher drug release than the other batches, indicating efficient
diffusion of the drug from the emulgel matrix. Antimicrobial evaluation using
the disc diffusion method revealed that formulation F2 produced the largest
zone of inhibition, signifying superior antimicrobial activity. This enhanced
efficacy may be attributed to improved drug release and greater interaction
between the drug and microbial cell membranes.
Overall,
the findings suggest that the optimized emulgel formulation possesses favorable
physicochemical characteristics, controlled drug release behavior, and
significant antimicrobial effectiveness. Therefore, it can be considered a
promising topical drug delivery system for the effective treatment of microbial
skin infections.
We
wish to express our sincere gratitude e to Mr. Jayadev Hiremath Sir and we are
also thankful to Dr. Ulka Idate, Microbiologist, Maratha Mandal's Central
Research Laboratory.